Loading market data...
Latest Top News
Show more
Solid Quarter, Strong Margins: Pfizer Reinforces Market Confidence
Pfizer Limited reported robust Q3 FY26 results with revenue rising nearly 20% year-on-year to 645 crore rupees and net profit climbing 11% to 141.8 crore rupees. EBITDA surged 56% to 228.3 crore rupees, driving margins higher. The performance reflects strong demand across therapy areas and improved cost efficiencies.
Stay Ahead – Explore Now! Singapore at the Core: Jaishankar’s Visit Reinforces India’s Act East Policy and Strategic Ties






